https://www.pharmaceutical-technology.com/data-insights/mazdutide-eli-lilly-and-co-net-present-value-2/
Mazdutide is a synthetic peptide commercialized by Eli Lilly and Co, with a leading Phase II program in Obesity.
net present valuerisk adjustedcurrentvaluation
https://www.prnewswire.com/apac/news-releases/innovent-announces-publication-of-mazdutide-ibi362-phase-2-full-results-in-chinese-patients-with-overweight-or-obesity-in-nature-communications-302017400.html
/PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...
full resultsannouncespublicationmazdutidephase